Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and dasatinib

pomalidomide has been researched along with dasatinib in 1 studies

Compound Research Comparison

Studies
(pomalidomide)		Trials
(pomalidomide)		Recent Studies (post-2010)
(pomalidomide)		Studies
(dasatinib)		Trials
(dasatinib)		Recent Studies (post-2010) (dasatinib)
6231215522,7072162,081

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)dasatinib (IC50)
Aurora kinase AHomo sapiens (human)2.633
Mitogen-activated protein kinase 13Homo sapiens (human)0.1
Receptor-interacting serine/threonine-protein kinase 2Homo sapiens (human)0.109
Bile salt export pumpHomo sapiens (human)10
Tyrosine-protein kinase ABL1Homo sapiens (human)0.9374
Proto-oncogene tyrosine-protein kinase SrcGallus gallus (chicken)0.1922
Epidermal growth factor receptorHomo sapiens (human)0.7144
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.164
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.71
Tyrosine-protein kinase LckHomo sapiens (human)0.0015
Proto-oncogene tyrosine-protein kinase LCK Mus musculus (house mouse)0.0004
Tyrosine-protein kinase FynHomo sapiens (human)0.0012
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.0078
Tyrosine-protein kinase YesHomo sapiens (human)0.0006
Tyrosine-protein kinase LynHomo sapiens (human)0.0012
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)1.2665
Tyrosine-protein kinase HCKHomo sapiens (human)0.001
Platelet-derived growth factor receptor betaHomo sapiens (human)0.028
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.0276
Breakpoint cluster region proteinHomo sapiens (human)0.4946
Fibroblast growth factor receptor 1Homo sapiens (human)0.88
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.0015
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.0365
Tyrosine-protein kinase BlkMus musculus (house mouse)0.008
Ephrin type-A receptor 2Homo sapiens (human)0.0689
Ephrin type-B receptor 2Homo sapiens (human)0.0044
Vascular endothelial growth factor receptor 2Homo sapiens (human)2.36
Dual specificity mitogen-activated protein kinase kinase 2Homo sapiens (human)1.7
Tyrosine-protein kinase CSKHomo sapiens (human)0.0013
Tyrosine-protein kinase TecHomo sapiens (human)0.297
Tyrosine-protein kinase TXKHomo sapiens (human)0.0003
Tyrosine-protein kinase SYKHomo sapiens (human)4.82
Casein kinase I isoform alphaHomo sapiens (human)0.001
LIM domain kinase 1Homo sapiens (human)0.6097
LIM domain kinase 2Homo sapiens (human)0.5186
Mitogen-activated protein kinase 12Homo sapiens (human)0.1
Ephrin type-B receptor 4Homo sapiens (human)0.001
Serine/threonine-protein kinase SIK1Homo sapiens (human)0.001
Myelin transcription factor 1Homo sapiens (human)0.063
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)1.7
Tyrosine-protein kinase BTKHomo sapiens (human)0.0036
Epithelial discoidin domain-containing receptor 1Homo sapiens (human)0.0143
Tyrosine-protein kinase ITK/TSKHomo sapiens (human)0.228
Protein-tyrosine kinase 6Homo sapiens (human)0.0071
Mitogen-activated protein kinase 11Homo sapiens (human)0.1
Mitogen-activated protein kinase 14Homo sapiens (human)0.1
Discoidin domain-containing receptor 2Homo sapiens (human)0.1127
Aurora kinase BHomo sapiens (human)6.485
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinaseHomo sapiens (human)0.104
Serine/threonine-protein kinase SIK2Homo sapiens (human)0.003
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)2
Serine/threonine-protein kinase SIK3Homo sapiens (human)0.005

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Ding, X; Elvassore, N; Jiang, B; Kong, Y; Liu, H; Liu, L; Mi, Q; Qiu, X; Ren, C; Shao, Y; Yang, X; Yin, Q; Zhao, Q1

Other Studies

1 other study(ies) available for pomalidomide and dasatinib

ArticleYear
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation.
    European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

    Topics: Animals; Cell Proliferation; Dasatinib; Drug Design; Fusion Proteins, bcr-abl; Half-Life; Humans; K562 Cells; Lenalidomide; Ligands; Mice; Neoplasms; Protein Kinase Inhibitors; Proteolysis; Structure-Activity Relationship; Thalidomide; Transplantation, Heterologous; Ubiquitin-Protein Ligases

2021